Additionally, we found that therapy with all three statins reduced VEGF-A levels in our study cohort, which is in agreement with prior studies in subjects with hypercholesterolemia[27], chronic coronary artery disease[28], and acute myocardial infarction[29]. The gene discussed is VEGFA; the disease is myocardial infarction.